was approved in May 2006 by the U.S. Food and Drug Administration (FDA) as a vaccine for use in adults ages 60 and over who have had chickenpox. Zostavax
is covered under most Medicare Part D plans, however Zostavax can be treated differently depending on the plan. In most cases Zostavax
is treated as a Tier 3 or Tier 4 medication and in some cases requires prior authorization or falls into the step therapy program.
Please check with your specific Medicare Part D plan to determine the handling of Zostavax.
Medications listed as treatments for Shingles are:
(generally a Medicare Part D Tier 3 medication) and
(generally a Medicare Part D Tier 2, 3 or Tier 4 medication - in some cases requiring prior authorization or step therapy)
Please Note: We are not medical doctors, nor are we pharmacists. The above information is strictly informational. Please consult your doctor or pharmacist when determining treatments.
Click the link below to see a list of how Zostavax
is handled on all stand-alone Medicare Part D plans in Florida: http://www.q1medicare.com/PartD-SearchPDPMedicarePartDDrugFinder.php?stateReg=11FL&ndc=00006496341&drug=ZOSTAVAX%20VIAL